Front. Oncol. Frontiers in Oncology Front. Oncol. 2234-943X Frontiers Media S.A. 10.3389/fonc.2022.1124071 Oncology Erratum Erratum: Patient-specific assays based on whole-genome sequencing data to measure residual disease in children with acute lymphoblastic leukemia: A proof of concept study Frontiers Production Office * Frontiers Media SA, Lausanne, Switzerland

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

*Correspondence: Frontiers Production Office, production.office@frontiersin.org

This article was submitted to Pediatric Oncology, a section of the journal Frontiers in Oncology

 04 01 2023 2022 12 1124071 14 12 2022 14 12 2022 Copyright © 2023 Frontiers Production Office 2023 Frontiers Production Office

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 An Erratum on Patient-specific assays based on whole-genome sequencing data to measure residual disease in children with acute lymphoblastic leukemia: A proof-of-concept study by Arthur C, Rezayee F, Mogensen N, Saft L, Rosenquist R, Nordenskjöld M, Harila-Saari A, Tham E and Barbany G (2022) Front. Oncol. 12:899325. doi: 10.3389/fonc.2022.899325 acute lymphoblastic leukemia liquid biopsy disease monitoring precision medicine whole-genome sequencing structural variation technical feasibility diagnostic performance

Due to a production error, there was a mistake in Figure 6 as published. The part labels in the figure were not placed correctly. The corrected Figure 6 appears below. The publisher apologizes for this mistake.

(A–D) Kinetics of leukemic targets in CSF and plasma by ddPCR during treatment. (A) CSF and (B) plasma results in patient 3. (C) CSF and (D) plasma results in patient 4. Empty symbols denote trace values (1–2 positive droplets). CSF, cerebrospinal fluid; ddPCR, droplet digital PCR.

The original version of this article has been updated.